Cited by 232Extracellular vesicles in diseaseLiver Disease Diagnosis and TreatmentLiver physiology and pathology

The DOI matches its Crossref record, with a small difference in title or year; 41 of the 41 references it cites were found in a registry or an index.

Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes

Open access

Ibrahim, Samar H., Hirsova, Petra, Tomita, Kyoko, Bronk, Steven F., Werneburg, Nathan W., Harrison, Stephen A., Goodfellow, Val S., Malhi, Harmeet, Gores, Gregory J.·2016·Hepatology

DOI 10.1002/hep.28252PMC PMC4764421

Open this paper in CoChat — free account

Abstract

Mixed lineage kinase 3 (MLK3) deficiency reduces macrophage‐associated inflammation in a murine model of nonalcoholic steatohepatitis (NASH). However, the mechanistic links between MLK3 activation in hepatocytes and macrophage‐driven inflammation in NASH are uncharted. Herein, we report that MLK3 mediates the release of (C‐X‐C motif) ligand 10 (CXCL10)‐laden extracellular vesicles (EVs) from lipotoxic hepatocytes, which induce macrophage chemotaxis. Primary mouse hepatocytes (PMHs) and Huh7 cells were treated with palmitate or lysophosphatidylcholine (LPC). Released EVs were isolated by differential ultracentrifugation. LPC treatment of PMH or Huh7 cells induced release of EVs, which was prevented by either genetic or pharmacological inhibition of MLK3. Mass spectrometry identified the potent chemokine, CXCL10, in the EVs, which was markedly enriched in EVs isolated from LPC‐treated hepatocytes versus untreated cells. Green fluorescent protein (GFP)‐tagged CXCL10 was present in vesicular structures and colocalized with the red fluorescent protein (RFP)‐tagged EV marker, CD63, after LPC treatment of cotransfected Huh‐7 cells. Either genetic deletion or pharmacological inhibition of MLK3 prevented CXCL10 enrichment in EVs. Treatment of mouse bone‐marrow–derived macrophages with lipotoxic hepatocyte‐derived EVs induced macrophage chemotaxis, an effect blocked by incubation with CXCL10‐neutralizing antisera. MLK3‐deficient mice fed a NASH‐inducing diet had reduced concentrations of total plasma EVs and CXCL10 containing EVs compared to wild‐type mice. Conclusions: During hepatocyte lipotoxicity, activated MLK3 induces the release of CXCL10‐bearing vesicles from hepatocytes, which are chemotactic for macrophages. (H epatology 2016;63:731–744)

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1002/hep.28252

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Tissue-based map of the human proteome
Uhlén, M., Fagerberg, L., Hallström, B. M., Lindskog, C., Oksvold, P., Mardinoglu, A., Sivertsson, Å., Kampf, C., Sjöstedt, E., Asplund, A., et al. (2015) · Science · doi:10.1126/science.1260419 · Cited by 15,286
Extracellular vesicles: Exosomes, microvesicles, and friends
Raposo, G., & Stoorvogel, W. (2013) · Journal of Cell Biology · doi:10.1083/jcb.201211138 · Cited by 8,099
Isolation and Characterization of Exosomes from Cell Culture Supernatants and Biological Fluids
Théry, C., Amigorena, S., Raposo, G., & Clayton, A. (2006) · Current Protocols in Cell Biology · doi:10.1002/0471143030.cb0322s30 · Cited by 5,766
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
The Natural History of Nonalcoholic Fatty Liver Disease: A Population-Based Cohort Study
Adams, L. A., Lymp, J. F., St. Sauver, J., Sanderson, S. O., Lindor, K. D., Feldstein, A., & Angulo, P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.04.014 · Cited by 2,890
Long-term follow-up of patients with NAFLD and elevated liver enzymes
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Thorelius, L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2006) · Hepatology · doi:10.1002/hep.21327 · Cited by 2,302
Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles
Colombo, M., Moita, C. F., van Niel, G., Kowal, J., Vigneron, J., Benaroch, P., Manel, N., Moita, L. F., Théry, C., & Raposo, G. (2013) · Journal of Cell Science · doi:10.1242/jcs.128868 · Cited by 1,534
Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis
Feldstein, A. E., Canbay, A., Angulo, P., Taniai, M., Burgart, L. J., Lindor, K. D., & Gores, G. J. (2003) · Gastroenterology · doi:10.1016/s0016-5085(03)00907-7 · Cited by 1,085
Self-citation
Hepatic lipotoxicity and the pathogenesis of nonalcoholic steatohepatitis: The central role of nontriglyceride fatty acid metabolites†
Neuschwander‐Tetri, B. A. (2010) · Hepatology · doi:10.1002/hep.23719 · Cited by 1,077
CXCR3 ligands: redundant, collaborative and antagonistic functions
Groom, J. R., & Luster, A. D. (2011) · Immunology and Cell Biology · doi:10.1038/icb.2010.158 · Cited by 1,006

Flagged first, then by citations

Show all 41 references

Sorted by citations

Liver inflammation and fibrosis
Koyama, Y., & Brenner, D. A. (2017) · Journal of Clinical Investigation · doi:10.1172/jci88881 · Cited by 1,295
Triggering and resolution of inflammation in NASH
Schuster, S., Cabrera, D., Arrese, M., & Feldstein, A. E. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0009-6 · Cited by 943
The role of macrophages in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis
Kazankov, K., Jørgensen, S. M. D., Thomsen, K. L., Møller, H. J., Vilstrup, H., George, J., Schuppan, D., & Grønbæk, H. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-018-0082-x · Cited by 941
Exosomes as mediators of intercellular crosstalk in metabolism
Isaac, R., Reis, F. C. G., Ying, W., & Olefsky, J. M. (2021) · Cell Metabolism · doi:10.1016/j.cmet.2021.08.006 · Cited by 860
Understanding lipotoxicity in NAFLD pathogenesis: is CD36 a key driver?
Rada, P., González‐Rodríguez, Á., García‐Monzón, C., & Valverde, Á. M. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-03003-w · Cited by 544
The effect of palmitic acid on inflammatory response in macrophages: an overview of molecular mechanisms
Korbecki, J., & Bajdak-Rusinek, K. (2019) · Inflammation Research · doi:10.1007/s00011-019-01273-5 · Cited by 558
How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?
Geng, Y., Faber, K. N., de Meijer, V. E., Blokzijl, H., & Moshage, H. J. (2021) · Hepatology International · doi:10.1007/s12072-020-10121-2 · Cited by 465
Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis
Musso, G., Cassader, M., Paschetta, E., & Gambino, R. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.06.031 · Cited by 332
Extracellular vesicles: mediators of intercellular communication in tissue injury and disease
Sánchez, G. B., Bunn, K. E., Pua, H. H., & Rafat, M. (2021) · Cell Communication and Signaling · doi:10.1186/s12964-021-00787-y · Cited by 297
Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets
Szabó, G., & Momen‐Heravi, F. (2017) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.71 · Cited by 286
Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation
Ibrahim, S. H., Hirsova, P., & Gores, G. J. (2018) · Gut · doi:10.1136/gutjnl-2017-315691 · Cited by 278
Self-citation
Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis
Hirsova, P., Ibrabim, S. H., Gores, G. J., & Malhi, H. (2016) · Journal of Lipid Research · doi:10.1194/jlr.r066357 · Cited by 270
Hepatocyte-derived extracellular vesicles promote endothelial inflammation and atherogenesis via microRNA-1
Jiang, F., Chen, Q., Wang, W., Ling, Y., Yan, Y., & Xia, P. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.09.014 · Cited by 279
Cellular Mechanisms of Liver Fibrosis
Acharya, P., Chouhan, K., Weiskirchen, S., & Weiskirchen, R. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.671640 · Cited by 252
Extracellular Vesicles in Liver Pathobiology: Small Particles With Big Impact
Hirsova, P., Ibrahim, S. H., Verma, V. K., Morton, L. A., Shah, V. H., LaRusso, N. F., Gores, G. J., & Malhi, H. (2016) · Hepatology · doi:10.1002/hep.28814 · Cited by 229
Self-citation
Immunological mechanisms and therapeutic targets of fatty liver diseases
Wang, H., Mehal, W. Z., Nagy, L. E., & Rotman, Y. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00579-3 · Cited by 234
Liver fibrosis in NAFLD/NASH: from pathophysiology towards diagnostic and therapeutic strategies
Parola, M., & Pinzani, M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101231 · Cited by 239
Integrin β1-enriched extracellular vesicles mediate monocyte adhesion and promote liver inflammation in murine NASH
Guo, Q., Furuta, K., Lucien, F., Sanchez, L. H. G., Hirsova, P., Krishnan, A., Kabashima, A., Pavelko, K. D., Madden, B. J., Alhuwaish, H., et al. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.07.019 · Cited by 185
Self-citation
Pathophysiological mechanisms underlying MAFLD
Kuchay, M. S., Choudhary, N. S., & Mishra, S. K. (2020) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2020.09.026 · Cited by 188
Neutrophil-to-hepatocyte communication via LDLR-dependent miR-223–enriched extracellular vesicle transfer ameliorates nonalcoholic steatohepatitis
He, Y., Rodrigues, R. M., Wang, X., Seo, W., Ma, J., Hwang, S., Fu, Y., Trojnár, E., Mátyás, C., Zhao, S., et al. (2021) · Journal of Clinical Investigation · doi:10.1172/jci141513 · Cited by 165
Macrophage Phenotype and Function in Liver Disorder
Dou, L., Shi, X., He, X., & Gao, Y. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2019.03112 · Cited by 187
New insights into the role and mechanism of c‐Jun‐N‐terminal kinase signaling in the pathobiology of liver diseases
Win, S., Than, T. A., Zhang, J., Oo, C., Min, R. W. M., & Kaplowitz, N. (2017) · Hepatology · doi:10.1002/hep.29689 · Cited by 171
Large Extracellular Vesicles: Have We Found the Holy Grail of Inflammation?
Słomka, A., Urban, S. K., Kornek, M., Żekanowska, E., & Kornek, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02723 · Cited by 166
MicroRNA‐223 Ameliorates Nonalcoholic Steatohepatitis and Cancer by Targeting Multiple Inflammatory and Oncogenic Genes in Hepatocytes
He, Y., Hwang, S., Cai, Y., Kim, S., Xu, M., Yang, D., Guillot, A., Feng, D., Seo, W., Hou, X., et al. (2019) · Hepatology · doi:10.1002/hep.30645 · Cited by 151
Lipid-induced endothelial vascular cell adhesion molecule 1 promotes nonalcoholic steatohepatitis pathogenesis
Furuta, K., Guo, Q., Pavelko, K. D., Lee, J.-H., Robertson, K. D., Nakao, Y., Melek, J., Shah, V. H., Hirsova, P., & Ibrahim, S. H. (2021) · Journal of Clinical Investigation · doi:10.1172/jci143690 · Cited by 136
Self-citation
Non-alcoholic Fatty Liver Disease and Alcohol-Related Liver Disease: Two Intertwined Entities
Idalsoaga, F., Kulkarni, A. V., Mousa, O. Y., Arrese, M., & Arab, J. P. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.00448 · Cited by 136
The Influence of Sex Hormones in Liver Function and Disease
Kasarinaite, A., Sinton, M. C., Saunders, P. T. K., & Hay, D. C. (2023) · Cells · doi:10.3390/cells12121604 · Cited by 139
CXCL10-Mediates Macrophage, but not Other Innate Immune Cells-Associated Inflammation in Murine Nonalcoholic Steatohepatitis
Tomita, K., Freeman, B. L., Bronk, S. F., LeBrasseur, N. K., White, T. A., Hirsova, P., & Ibrahim, S. H. (2016) · Scientific Reports · doi:10.1038/srep28786 · Cited by 130
Self-citation
Hepatocytes: A key role in liver inflammation
Gong, J., Tu, W., Liu, J., & Tian, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1083780 · Cited by 152
Cholangiocyte-Derived Exosomal lncRNA H19 Promotes Macrophage Activation and Hepatic Inflammation under Cholestatic Conditions
Li, X., Liu, R., Wang, Y., Zhu, W., Zhao, D., Wang, X., Yang, H., Gurley, E. C., Chen, W., Hylemon, P. B., et al. (2020) · Cells · doi:10.3390/cells9010190 · Cited by 120
Understanding the cellular interactome of non-alcoholic fatty liver disease
Wallace, S. J., Tacke, F., Schwabe, R. F., & Henderson, N. C. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100524 · Cited by 116
Extracellular vesicles: Novel mediator for cell to cell communications in liver pathogenesis
Devhare, P. B., & Ray, R. B. (2017) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2017.11.001 · Cited by 119
Crosstalk Between Liver Macrophages and Surrounding Cells in Nonalcoholic Steatohepatitis
Li, H., Zhou, Y., Wang, H., Zhang, M., Qiu, P., Zhang, M., Zhang, R., Zhao, Q., & Liu, J. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01169 · Cited by 117
Therapeutic effects of serum extracellular vesicles in liver fibrosis
Chen, L., Chen, R., Kemper, S., Cong, M., You, H., & Brigstock, D. R. (2018) · Journal of Extracellular Vesicles · doi:10.1080/20013078.2018.1461505 · Cited by 114
Current understanding of the role of Adipose-derived Extracellular Vesicles in Metabolic Homeostasis and Diseases: Communication from the distance between cells/tissues
Li, C., Fang, Q., Liu, M., & Lin, J. (2020) · Theranostics · doi:10.7150/thno.42167 · Cited by 118
Hepatic stellate cell–derived platelet‐derived growth factor receptor‐alpha‐enriched extracellular vesicles promote liver fibrosis in mice through SHP2
Kostallari, E., Hirsova, P., Prasnicka, A., Verma, V. K., Yaqoob, U., Wongjarupong, N., Roberts, L. R., & Shah, V. H. (2018) · Hepatology · doi:10.1002/hep.29803 · Cited by 111
Self-citation
Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content
Sasaki, Y., Asahiyama, M., Tanaka, T., Yamamoto, S., Murakami, K., Kamiya, W., Matsumura, Y., Osawa, T., Anai, M., Fruchart, J., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-64902-8 · Cited by 110
Mitochondrial DNA–enriched microparticles promote acute-on-chronic alcoholic neutrophilia and hepatotoxicity
Cai, Y., Xu, M., Koritzinsky, E. H., Zhou, Z., Wang, W., Cao, H., Yuen, P. S. T., Ross, R. A., Star, R. A., Liangpunsakul, S., et al. (2017) · JCI Insight · doi:10.1172/jci.insight.92634 · Cited by 109
The Role of the Dysregulated JNK Signaling Pathway in the Pathogenesis of Human Diseases and Its Potential Therapeutic Strategies: A Comprehensive Review
Yan, H., He, L., Lv, D., Yang, J., & Yuan, Z. (2024) · Biomolecules · doi:10.3390/biom14020243 · Cited by 112
Regulation and functional roles of chemokines in liver diseases
Cao, S., Liu, M., Sehrawat, T. S., & Shah, V. H. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-021-00444-2 · Cited by 106
Exosome-Mediated Impact on Systemic Metabolism
Rocha, K. C. E., Ying, W., & Olefsky, J. M. (2024) · Annual Review of Physiology · doi:10.1146/annurev-physiol-042222-024535 · Cited by 103
The role of extracellular vesicles in mediating progression, metastasis and potential treatment of hepatocellular carcinoma
Yang, N., Li, S., Li, G., Zhang, S., Tang, X., Ni, S., Jian, X.-M., Xu, C., Zhu, J., & Lu, M. (2016) · Oncotarget · doi:10.18632/oncotarget.12465 · Cited by 102
Liquid biopsy for liver diseases
Mann, J., Reeves, H. L., & Feldstein, A. E. (2018) · Gut · doi:10.1136/gutjnl-2017-315846 · Cited by 95
Chemokines and Chemokine Receptors in the Development of NAFLD
Roh, Y., & Seki, E. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-8684-7_4 · Cited by 94
Role of extracellular vesicles in liver diseases and their therapeutic potential
Kostallari, E., Valainathan, S. R., Biquard, L., Shah, V. H., & Rautou, P. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.026 · Cited by 93
Pathophysiological underpinnings of metabolic dysfunction-associated steatotic liver disease
Kuchay, M. S., Choudhary, N. S., & Ramos‐Molina, B. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00951.2024 · Cited by 104
Puerarin protects against high‐fat high‐sucrose diet‐induced non‐alcoholic fatty liver disease by modulating PARP‐1/PI3K/AKT signaling pathway and facilitating mitochondrial homeostasis
Wang, S., Yang, F., Shang, L., Zhang, Y., Zhou, Y., & Shi, X. (2019) · Phytotherapy Research · doi:10.1002/ptr.6417 · Cited by 91
Hepatic steatosis aggravates atherosclerosis via small extracellular vesicle-mediated inhibition of cellular cholesterol efflux
Chen, X., Chen, S., Pang, J., Huang, R., You, Y., Zhang, H., Xiao, J., Xue, H., & Ling, W. (2023) · Journal of Hepatology · doi:10.1016/j.jhep.2023.08.023 · Cited by 97
Oxidative Stress in Non-Alcoholic Fatty Liver Disease
Smirne, C., Croce, E., Benedetto, D. D., Cantaluppi, V., Comi, C., Sainaghi, P. P., Minisini, R., Grossini, E., & Pirisi, M. (2022) · Livers · doi:10.3390/livers2010003 · Cited by 100
Activation of Kupffer cells in NAFLD and NASH: mechanisms and therapeutic interventions
Xu, G.-X., Song, W., Yu, C., Zhao, S., Yang, W., Feng, Y.-H., Pan, C., Kun-xing, Y., & Ma, Y. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1199519 · Cited by 93
To die or not to die: death signaling in nonalcoholic fatty liver disease
Akazawa, Y., & Nakao, K. (2018) · Journal of Gastroenterology · doi:10.1007/s00535-018-1451-5 · Cited by 81
Hepatocyte TNF Receptor–Associated Factor 6 Aggravates Hepatic Inflammation and Fibrosis by Promoting Lysine 6–Linked Polyubiquitination of Apoptosis Signal‐Regulating Kinase 1
Wang, Y., Wen, H., Fu, J., Cai, L., Li, P., Zhao, C., Dong, Z., Ma, J., Wang, X., Tian, H., et al. (2019) · Hepatology · doi:10.1002/hep.30822 · Cited by 79
MicroRNAs in the Pathogenesis of Nonalcoholic Fatty Liver Disease
Fang, Z., Dou, G., & Wang, L. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.59588 · Cited by 83
Pathogenesis of Nonalcoholic Steatohepatitis and Hormone-Based Therapeutic Approaches
Kim, K. H., & Lee, M. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00485 · Cited by 77
Advances on liver cell‐derived exosomes in liver diseases
Yan, J., Xu, P., Shi, H., Chen, D., & Shi, H. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16123 · Cited by 76
A longitudinal study of whole body, tissue, and cellular physiology in a mouse model of fibrosing NASH with high fidelity to the human condition
Krishnan, A., Abdullah, T. S., Mounajjed, T., Hartono, S. P., McConico, A. L., White, T., LeBrasseur, N. K., Lanza, I. R., Nair, S., Gores, G., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00213.2016 · Cited by 75
Self-citation
Liver sinusoidal endothelial cell expressed vascular cell adhesion molecule 1 promotes liver fibrosis
Guo, Q., Furuta, K., Islam, S., Caporarello, N., Kostallari, E., Dielis, K., Tschumperlin, D. J., Hirsova, P., & Ibrahim, S. H. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.983255 · Cited by 73
Self-citation
Hepatic Macrophage as a Key Player in Fatty Liver Disease
Xu, L., Liu, W., Bai, F., Xu, Y., Liang, X., Ma, C., & Gao, L. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.708978 · Cited by 73
Extracellular vesicles, the liquid biopsy of the future
Eguchi, A., Kostallari, E., Feldstein, A. E., & Shah, V. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.01.030 · Cited by 71
Antigen presentation, autoantibody production, and therapeutic targets in autoimmune liver disease
Horst, A. K., Kumashie, K. G., Neumann, K., Diehl, L., & Tiegs, G. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00568-6 · Cited by 73
The immune landscape in nonalcoholic steatohepatitis
Narayanan, S., Surette, F. A., & Hahn, Y. S. (2016) · Immune Network · doi:10.4110/in.2016.16.3.147 · Cited by 64
Intercellular Communication between Hepatic Cells in Liver Diseases
Sato, K., Kennedy, L. L., Liangpunsakul, S., Kusumanchi, P., Yang, Z., Meng, F., Glaser, S. S., Francis, H., & Alpini, G. D. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092180 · Cited by 73
Role of macrophages in experimental liver injury and repair in mice (Review)
Dong, X., Liu, J., Xu, Y., & Cao, H. (2019) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2019.7450 · Cited by 74
Extracellular Vesicles in NAFLD/ALD: From Pathobiology to Therapy
Hernández, A., Arab, J. P., Reyes, D., Lapitz, A., Moshage, H. J., Bañales, J. M., & Arrese, M. A. (2020) · Cells · doi:10.3390/cells9040817 · Cited by 67
Lipidomics in pathogenesis, progression and treatment of nonalcoholic steatohepatitis (NASH): Recent advances
Musso, G., Saba, F., Cassader, M., & Gambino, R. (2023) · Progress in Lipid Research · doi:10.1016/j.plipres.2023.101238 · Cited by 71
Therapeutic opportunities for alcoholic steatohepatitis and nonalcoholic steatohepatitis: exploiting similarities and differences in pathogenesis
Greuter, T., Malhi, H., Gores, G. J., & Shah, V. H. (2017) · JCI Insight · doi:10.1172/jci.insight.95354 · Cited by 67
Self-citation
Kupffer cells promote T-cell hepatitis by producing CXCL10 and limiting liver sinusoidal endothelial cell permeability
Dai, S., Liu, F., Qin, Z., Zhang, J., Chen, J., Ding, W., Feng, D., Ji, Y. I., & Qin, X. (2020) · Theranostics · doi:10.7150/thno.44960 · Cited by 66
Extracellular Vesicles as Inflammatory Drivers in NAFLD
Srinivas, A. N., Suresh, D., Santhekadur, P. K., Suvarna, D., & Kumar, D. P. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.627424 · Cited by 65
Extracellular vesicles in non-alcoholic and alcoholic fatty liver diseases
Eguchi, A., & Feldstein, A. E. (2018) · Liver Research · doi:10.1016/j.livres.2018.01.001 · Cited by 62
Novel Molecular Mechanisms in the Development of Non-Alcoholic Steatohepatitis
Povero, D., & Feldstein, A. E. (2016) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2016.40.1.1 · Cited by 60
Therapeutic potential of traditional Chinese medicine for the treatment of NAFLD: A promising drug Potentilla discolor Bunge
Ji, L., Li, Q., He, Y., Zhang, X., Zhou, Z., Gao, Y., Fang, M., Yu, Z., Rodrigues, R. M., Gao, Y., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.05.001 · Cited by 62
A narrative review: CXC chemokines influence immune surveillance in obesity and obesity-related diseases: Type 2 diabetes and nonalcoholic fatty liver disease
Ullah, A., Din, A. U., Ding, W., Shi, Z., Pervaz, S., & Shen, B. (2023) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-023-09800-w · Cited by 60
The Role of Extracellular Vesicles in Disease Progression and Detection of Hepatocellular Carcinoma
Lee, Y., Tran, B. V., Wang, J. J., Liang, I. Y., You, S., Zhu, Y., Agopian, V. G., Tseng, H., & Yang, J. D. (2021) · Cancers · doi:10.3390/cancers13123076 · Cited by 57
Macrophagic Extracellular Vesicle CXCL2 Recruits and Activates the Neutrophil CXCR2/PKC/NOX4 Axis in Sepsis
Wang, G., Huang, W., Wang, S., Wang, J., Cui, W., Zhang, W., Lou, A., Geng, S., & Li, X. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100229 · Cited by 58
Extracellular vesicles in inflammation: Focus on the microRNA cargo of EVs in modulation of liver diseases
Babuta, M., & Szabó, G. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3mir0321-156r · Cited by 63
Comprehensive lipidomics reveals phenotypic differences in hepatic lipid turnover in ALD and NAFLD during alcohol intoxication
Israelsen, M. E., Kim, M. G., Suvitaival, T., Madsen, B. S., Hansen, C. D., Torp, N., Trôst, K., Thiele, M. S., Hansen, T. F., Legido‐Quigley, C., et al. (2021) · JHEP Reports · doi:10.1016/j.jhepr.2021.100325 · Cited by 57
Extracellular vesicles: Future diagnostic and therapeutic tools for liver disease and regeneration
Balaphas, A., Meyer, J., Sadoul, R., Morel, P., Gonelle‐Gispert, C., & Bühler, L. H. (2019) · Liver International · doi:10.1111/liv.14189 · Cited by 56
Shaping of Innate Immune Response by Fatty Acid Metabolite Palmitate
Tzeng, H., Chyuan, I., & Chen, W. (2019) · Cells · doi:10.3390/cells8121633 · Cited by 59
Mixed Lineage Kinase 3 Mediates the Induction of CXCL10 by a STAT1‐Dependent Mechanism During Hepatocyte Lipotoxicity
Tomita, K., Kabashima, A., Freeman, B. L., Bronk, S. F., Hirsova, P., & Ibrahim, S. H. (2017) · Journal of Cellular Biochemistry · doi:10.1002/jcb.25973 · Cited by 53
Self-citation
The functional roles of exosomes-derived long non-coding RNA in human cancer
Chen, F., Wang, N., Tan, H., Guo, W., Zhang, C., & Feng, Y. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1564562 · Cited by 53
Metabolic dysfunction-associated steatotic liver disease and extrahepatic gastrointestinal cancers
Mantovani, A., Lonardo, A., Stefan, N., & Targher, G. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156014 · Cited by 52
Circulating cell-specific extracellular vesicles as biomarkers for the diagnosis and monitoring of chronic liver diseases
Newman, L. A., Muller, K., & Rowland, A. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04256-8 · Cited by 58
Innate Immunity and MASLD
Meyer, M., Schwärzler, J., Jukic, A., & Tilg, H. (2024) · Biomolecules · doi:10.3390/biom14040476 · Cited by 50
Emerging role of extracellular vesicles in liver diseases
Malhi, H. (2019) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00183.2019 · Cited by 52
Self-citation
Emerging Roles of Liver Sinusoidal Endothelial Cells in Nonalcoholic Steatohepatitis
Furuta, K., Guo, Q., Hirsova, P., & Ibrahim, S. H. (2020) · Biology · doi:10.3390/biology9110395 · Cited by 49
Self-citation
Alcohol-Related Liver Disease: An Overview on Pathophysiology, Diagnosis and Therapeutic Perspectives
Ha, Y., Jeong, I., & Kim, T. H. (2022) · Biomedicines · doi:10.3390/biomedicines10102530 · Cited by 47
Hepatocyte nuclear receptor SHP suppresses inflammation and fibrosis in a mouse model of nonalcoholic steatohepatitis
Zou, A., Magee, N. S., Deng, F., Lehn, S., Zhong, C., & Zhang, Y. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra117.001653 · Cited by 47
Non-parenchymal hepatic cell lipotoxicity and the coordinated progression of non-alcoholic fatty liver disease and atherosclerosis
Peters, K. M., Wilson, R. B., & Borradaile, N. M. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000535 · Cited by 47
Novel Drivers of the Inflammatory Response in Liver Injury and Fibrosis
Wree, A., Holtmann, T. M., Inzaugarat, M. E., & Feldstein, A. E. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1685515 · Cited by 48
Bacterial and eukaryotic extracellular vesicles and nonalcoholic fatty liver disease: new players in the gut-liver axis?
Villard, A., Boursier, J., & Andriantsitohaina, R. (2021) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2020 · Cited by 49
Extracellular Vesicles in Liver Diseases: Diagnostic, Prognostic, and Therapeutic Application
Urban, S. K., Mocan, T., Sänger, H., Kornek, M., & Kornek, M. (2019) · Seminars in Liver Disease · doi:10.1055/s-0038-1676122 · Cited by 47
Adapted Immune Responses of Myeloid-Derived Cells in Fatty Liver Disease
Hundertmark, J., Krenkel, O., & Tacke, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02418 · Cited by 46
Extracellular Vesicles in the Development of the Non-Alcoholic Fatty Liver Disease: An Update
Dorairaj, V., Sulaiman, S. A., Abu, N., & Murad, N. A. A. (2020) · Biomolecules · doi:10.3390/biom10111494 · Cited by 47
Inflammation and Fibrogenesis in MAFLD: Role of the Hepatic Immune System
Torre, P., Motta, B. M., Sciorio, R., Masarone, M., & Persico, M. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.781567 · Cited by 49
The emerging roles of extracellular vesicles as intercellular messengers in liver physiology and pathology
Lee, Y., & Kim, J. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2021.0390 · Cited by 47
Extracellular Vesicles From Hepatocytes Are Therapeutic for Toxin-Mediated Fibrosis and Gene Expression in the Liver
Li, X., Chen, R., Kemper, S., & Brigstock, D. R. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00368 · Cited by 43
Programmed cell death and lipid metabolism of macrophages in NAFLD
Xiao, Z., Liu, M., Yang, F., Liu, G., Liu, J., Zhao, W., Ma, S., & Duan, Z. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1118449 · Cited by 42
TRAIL deletion prevents liver inflammation but not adipose tissue inflammation during murine diet‐induced obesity
Hirsova, P., Weng, P., Salim, W., Bronk, S. F., Griffith, T. S., Ibrahim, S. H., & Gores, G. J. (2017) · Hepatology Communications · doi:10.1002/hep4.1069 · Cited by 41
Self-citation
Extracellular Vesicles in Non-alcoholic Fatty Liver Disease and Alcoholic Liver Disease
Wu, D., Zhu, H., & Wang, H. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.707429 · Cited by 42
Diosmetin as a promising natural therapeutic agent: In vivo, in vitro mechanisms, and clinical studies
Sun, Z., Liu, K., Liang, C., Wen, L., Wu, J., Liu, X., & Li, X. (2024) · Phytotherapy Research · doi:10.1002/ptr.8214 · Cited by 43

Authors: Ibrahim, S. H., Hirsova, P., Tomita, K., Bronk, S. F., Werneburg, N. W., Harrison, S. A., Goodfellow, V. S., Malhi, H., & Gores, G. J.
Affiliations: Mayo Clinic (US)
Brooke Army Medical Center, Fort Sam Houston,Houston,TX
Califia Bio (United States) (US)
Corresponding author: Gores, Gregory J.
ORCID: Ibrahim, Samar H.
Hirsova, Petra
Harrison, Stephen A.
Malhi, Harmeet
Gores, Gregory J.
Venue: Hepatology
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2015-12-11
Volume: 63
Issue: 3
Pages: 731-744
ISSN: 0270-9139 (ISSN-L)
1527-3350
DOI: 10.1002/hep.28252
PMC: PMC4764421
OpenAlex: W2146229869
Cited by: 232
References: 41
Citations by year: 2026: 7 · 2025: 11 · 2024: 22 · 2023: 24 · 2022: 34 · 2021: 29 · 2020: 37 · 2019: 23 · 2018: 19 · 2017: 14 · 2016: 10 · 2015: 1
FWCI: 6.37
Type: journal article
Language: en
Update notices: correction (2016-08-01)
Open access: green
www.ncbi.nlm.nih.gov
Licence: doi.wiley.com/10.1002/tdm_license_1.1 (tdm)
onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Hepatology (publishedVersion)
PubMed (publishedVersion)
Europe PMC (PubMed Central) (acceptedVersion)
PubMed Central (acceptedVersion)
Funders: Mayo Clinic
National Institutes of Health (KL2TR000136, DK97178)
Center for Cell Signaling in Gastroenterology, Mayo Clinic (P30 DK084567)
National Institute of Diabetes and Digestive and Kidney Diseases (K08DK097178, DK-41876, R37DK041876, R01DK041876, P30DK084567, DK 97178)
National Center for Advancing Translational Sciences
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Extracellular vesicles in disease
Health Sciences › Medicine › Hepatology › Liver Disease Diagnosis and Treatment
Health Sciences › Medicine › Hepatology › Liver physiology and pathology
Keywords: MLK3, CXCL10, extracellular vesicles, lipotoxicity, hepatocytes, macrophage chemotaxis, nonalcoholic steatohepatitis, lysophosphatidylcholine, palmitate, chemokine secretion, CD63
MeSH terms: Extracellular Vesicles, Mitogen-Activated Protein Kinase Kinase Kinase 11, Animals, Chemotaxis, Disease Models, Animal, Humans, Liver, Macrophages, Signal Transduction, MAP Kinase Kinase Kinases, Hepatocytes, Cell Line, Tumor, Mice, Chemokine CXCL10, Non-alcoholic Fatty Liver Disease

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Mixed lineage kinase 3 mediates release of C‐X‐C motif ligand 10–bearing chemotactic extracellular vesicles from lipotoxic hepatocytes

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks